JP2025118972A5 - - Google Patents

Info

Publication number
JP2025118972A5
JP2025118972A5 JP2025084549A JP2025084549A JP2025118972A5 JP 2025118972 A5 JP2025118972 A5 JP 2025118972A5 JP 2025084549 A JP2025084549 A JP 2025084549A JP 2025084549 A JP2025084549 A JP 2025084549A JP 2025118972 A5 JP2025118972 A5 JP 2025118972A5
Authority
JP
Japan
Prior art keywords
cells
stem cells
rpe
medium containing
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025084549A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025118972A (ja
Filing date
Publication date
Priority claimed from JP2017535832A external-priority patent/JP2018502575A/ja
Application filed filed Critical
Publication of JP2025118972A publication Critical patent/JP2025118972A/ja
Publication of JP2025118972A5 publication Critical patent/JP2025118972A5/ja
Pending legal-status Critical Current

Links

JP2025084549A 2014-12-30 2025-05-21 網膜色素上皮細胞集団の評価法 Pending JP2025118972A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201462097753P 2014-12-30 2014-12-30
US62/097,753 2014-12-30
US201562116980P 2015-02-17 2015-02-17
US62/116,980 2015-02-17
US201562195304P 2015-07-22 2015-07-22
US62/195,304 2015-07-22
JP2017535832A JP2018502575A (ja) 2014-12-30 2015-12-30 網膜色素上皮細胞集団の評価法
JP2021020986A JP7723482B2 (ja) 2014-12-30 2021-02-12 網膜色素上皮細胞集団の評価法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021020986A Division JP7723482B2 (ja) 2014-12-30 2021-02-12 網膜色素上皮細胞集団の評価法

Publications (2)

Publication Number Publication Date
JP2025118972A JP2025118972A (ja) 2025-08-13
JP2025118972A5 true JP2025118972A5 (https=) 2025-10-27

Family

ID=55305031

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2017535832A Pending JP2018502575A (ja) 2014-12-30 2015-12-30 網膜色素上皮細胞集団の評価法
JP2020085170A Pending JP2020146044A (ja) 2014-12-30 2020-05-14 網膜色素上皮細胞集団の評価法
JP2021020986A Active JP7723482B2 (ja) 2014-12-30 2021-02-12 網膜色素上皮細胞集団の評価法
JP2023038688A Pending JP2023078266A (ja) 2014-12-30 2023-03-13 網膜色素上皮細胞集団の評価法
JP2025084549A Pending JP2025118972A (ja) 2014-12-30 2025-05-21 網膜色素上皮細胞集団の評価法

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2017535832A Pending JP2018502575A (ja) 2014-12-30 2015-12-30 網膜色素上皮細胞集団の評価法
JP2020085170A Pending JP2020146044A (ja) 2014-12-30 2020-05-14 網膜色素上皮細胞集団の評価法
JP2021020986A Active JP7723482B2 (ja) 2014-12-30 2021-02-12 網膜色素上皮細胞集団の評価法
JP2023038688A Pending JP2023078266A (ja) 2014-12-30 2023-03-13 網膜色素上皮細胞集団の評価法

Country Status (8)

Country Link
US (2) US20180011092A1 (https=)
EP (2) EP3916085A1 (https=)
JP (5) JP2018502575A (https=)
AU (3) AU2015373051B2 (https=)
CA (1) CA2972580A1 (https=)
ES (1) ES2880346T3 (https=)
IL (2) IL314417A (https=)
WO (1) WO2016108240A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2972575A1 (en) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Rpe cell populations and methods of generating same
EP3240612B1 (en) 2014-12-30 2020-12-23 Cell Cure Neurosciences Ltd. Methods of treating retinal diseases
WO2017017686A1 (en) * 2015-07-29 2017-02-02 Hadasit Medical Research Services And Development Ltd. Large scale production of retinal pigment epithelial cells
US11066642B2 (en) * 2015-08-05 2021-07-20 Cell Cure Neurosciences Ltd Preparation of retinal pigment epithelium cells
EP3331995A1 (en) * 2015-08-05 2018-06-13 Cell Cure Neurosciences Ltd. Preparation of photoreceptors for the treatment of retinal diseases
KR102428209B1 (ko) * 2017-06-23 2022-08-02 주하이 에섹스 바이오-파머슈티컬 코., 엘티디. 가용성 재조합 인간-염기성 섬유아세포 성장 인자 (rh-bFGF)를 제조하는 방법
WO2019130061A2 (en) 2017-12-29 2019-07-04 Cell Cure Neurosciences Ltd. Retinal pigment epithelium cell compositions
JP2024527986A (ja) * 2021-07-28 2024-07-26 リネージ セル セラピューティクス インコーポレイテッド 網膜色素上皮細胞の増殖
WO2026028838A1 (ja) * 2024-07-31 2026-02-05 コニカミノルタ株式会社 細胞の分析方法及び目的物質の生産方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
SG49267A1 (en) 1989-08-14 1998-05-18 Photogenesis Inc Surgical instrument and cell isolation and transplantation
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US6045791A (en) 1992-03-06 2000-04-04 Photogenesis, Inc. Retinal pigment epithelium transplantation
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5755785A (en) 1994-08-12 1998-05-26 The University Of South Florida Sutureless corneal transplantation method
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5941250A (en) 1996-11-21 1999-08-24 University Of Louisville Research Foundation Inc. Retinal tissue implantation method
GB9715584D0 (en) 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
GB0001930D0 (en) 2000-01-27 2000-03-22 Novartis Ag Organic compounds
EE200300360A (et) 2001-01-31 2003-12-15 Pfizer Products Inc. PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
AU2003201745A1 (en) 2002-02-11 2003-09-04 Pfizer Limited Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
WO2006040763A2 (en) 2004-10-12 2006-04-20 Technion Research & Development Foundation Ltd. Isolated primate embryonic cells and methods of generating and using same
EP1844136B1 (en) 2004-12-29 2014-08-27 Hadasit Medical Research Services And Development Ltd. Stem cells culture systems
US20080003676A1 (en) * 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells
EP2128244A4 (en) 2007-01-18 2012-05-09 Riken PROCESS FOR INDUCTION / DIFFERENTIATION TO A PHOTOREZEPTORZELLE
EP2147094B2 (en) 2007-04-18 2018-02-21 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
US20090226955A1 (en) * 2007-12-21 2009-09-10 University Of Miami Immortalized retinal pigmented epithelial cells
IL281453B (en) 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
US20120258451A1 (en) 2011-04-08 2012-10-11 Advanced Cell Technology, Inc. Laser isolation of viable cells
IL287381B2 (en) 2011-11-14 2024-04-01 Astellas Inst For Regenerative Medicine Pharmaceutical preparations of human rpe cells and uses thereof
AU2013216382B2 (en) 2012-01-31 2018-08-02 Hadasit Medical Research Services And Development Ltd. Methods of selecting retinal pigmented epithelial cells
US9850463B2 (en) 2012-02-01 2017-12-26 The Regents Of The University Of California Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation
CN102618497B (zh) * 2012-03-15 2013-10-02 中国人民解放军第三军医大学第一附属医院 利用人骨髓间充质干细胞制备视网膜色素上皮细胞的方法
US9458428B2 (en) 2012-06-05 2016-10-04 The Regents Of The University Of California Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells
EP2951290B1 (en) 2013-02-01 2017-11-29 The United States of America, as represented by The Secretary, Department of Health and Human Services Method for generating retinal pigment epithelium (rpe) cells from induced pluripotent stem cells (ipscs)
MX2016007671A (es) * 2013-12-11 2016-10-14 Pfizer Ltd Metodo para producir celulas del epitelio pigmentario retiniano.
WO2015175504A1 (en) 2014-05-12 2015-11-19 The Johns Hopkins University Differentiation of human pluripotent stem cells into retinal pigment epithelium using hif1 inhibitors
EP3240612B1 (en) 2014-12-30 2020-12-23 Cell Cure Neurosciences Ltd. Methods of treating retinal diseases
CA2972575A1 (en) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Rpe cell populations and methods of generating same

Similar Documents

Publication Publication Date Title
JP2025118972A5 (https=)
Vazin et al. Human embryonic stem cells: derivation, culture, and differentiation: a review
AU2022291461B2 (en) Preparation of retinal pigment epithelium cells
US20250215394A1 (en) Preparation of retinal pigment epithelium cells
JP7055095B2 (ja) 網膜色素上皮細胞の大規模生産
JP6868608B2 (ja) 網膜疾患の処置のための光受容体の調製
Yang et al. Plasticity of epidermal adult stem cells derived from adult goat ear skin
CN103146572A (zh) 一种实现细胞集落均质性生长的装置和方法
CA2596231A1 (en) Methods for embryonic stem cell culture
JP2018502576A5 (https=)
TWI397414B (zh) 感溫性細胞組織移植支架之層合物及其用途
JP2018502575A5 (https=)
WO2017043604A1 (ja) 網膜組織の製造方法
Mahato et al. Generation of retinal organoids from healthy and retinal disease-specific human-induced pluripotent stem cells
EP3987012A1 (en) Automated method for preparing retinal pigment epithelium cells
US12618045B2 (en) Automated method for preparing retinal pigment epithelium cells
Chatterji et al. Ocular stem cells to treat retinal and corneal disorders
KR102083735B1 (ko) 유도만능줄기세포를 이용한 치계모세포로의 분화방법 및 이의 용도
Lachaud et al. Corneal stem cells: identification and methods of ex vivo expansion
Bosch Canals A bioengineering approach for corneal endothelial regeneration.
HK40104125A (zh) 视网膜色素上皮细胞的扩增
MXPA06008299A (en) Improved modalities for the treatment of degenerative diseases of the retina